Pegylated Interferon Wins FDA Approval for Polycythemia Vera

(MedPage Today) -- The FDA granted a first-ever approval of an interferon for the rare blood disorder polycythemia vera (PV), also making ropeginterferon alfa-2b-njft (Besremi) the first approved PV therapy that patients can receive regardless...